Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Oct 4, 2022
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2022-09-30$0.22/sh−353$79→ 173,359 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.